China Sxt Pharmaceuticals Inc (SXTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 03-2021 | 03-2020 | 03-2019 | 03-2018 | 03-2017 | |
| Sales | 4,778 | 5,162 | 7,012 | 7,019 | 4,882 |
| Cost of Goods | 1,938 | 2,459 | 2,401 | 3,618 | 2,570 |
| Gross Profit | 2,840 | 2,704 | 4,612 | 3,402 | 2,312 |
| Operating Expenses | 5,975 | 4,503 | 3,243 | 2,387 | 1,279 |
| Operating Income | -2,197 | -1,341 | 1,770 | 1,632 | 1,602 |
| Interest Expense | 1,615 | 3,349 | 5 | 1 | 40 |
| Other Income | 872 | -5,700 | 27 | -4 | 18 |
| Pre-tax Income | -2,941 | -10,390 | 1,792 | 1,628 | 1,580 |
| Income Tax | -193 | -102 | 252 | 440 | 395 |
| Net Income Continuous | -2,748 | -10,288 | 1,539 | 1,188 | 1,185 |
| Net Income | $-2,748 | $-10,288 | $1,539 | $1,188 | $1,185 |
| EPS Basic Total Ops | -114,000.00 | -1.66 | 0.08 | 0.06 | 0.06 |
| EPS Basic Continuous Ops | -114,009.40 | -1.66 | 0.07 | 0.06 | 0.06 |
| EPS Diluted Total Ops | -114,000.00 | -1.66 | 0.08 | 0.06 | 0.06 |
| EPS Diluted Continuous Ops | -114,009.40 | -1.66 | 0.07 | 0.06 | 0.06 |
| EBITDA(a) | $-1,852 | $-1,009 | $1,950 | $1,762 | $1,701 |